Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Revizinone is a novel selective phosphodiesterase inhibitor with IC50 values on this enzyme to 0.036 microM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | 10-14 weeks | $ 498.00 | |
100 mg | 10-14 weeks | $ 769.00 |
Description | Revizinone is a novel selective phosphodiesterase inhibitor with IC50 values on this enzyme to 0.036 microM. |
In vitro | Revizinone significantly increased global LV function and systolic wall thickening in ischemic areas at doses greater than or equal to 0.16 mg/kg i.v. The administration of Revizinone improved the hemodynamic profile with an increase in cardiac output, a decrease in systemic vascular resistance, and a stable heart rate and mean arterial blood pressure. With regard to the reconstitution of contractility and cardiac function Revizinone (E-isomer) was 10 fold more potent than R 79595 and nearly 100 fold more potent than R 80123 (Z-isomer) [1] [2][4]. |
Synonyms | R80122 |
Molecular Weight | 459.54 |
Formula | C26H29N5O3 |
CAS No. | 133718-29-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.6 mg/mL (10.01 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Revizinone 133718-29-3 Others R80122 R 80122 R-80122 inhibitor inhibit